We all benefit from investing in biomedical research through the NIH
Investing in biomedical research at the National Institutes of Health (NIH) not only saves lives and boosts the economy, it also has an intensely personal impact right here at home. I am one of the estimated 40,000 Michiganians living with Parkinson’s disease, for which there is no cure, nor treatment to halt this disease’s cruel progression.
The National Institute of Health is the single largest funder of medical research in the United States, and the research it funds drives innovation and has the potential to improve the lives of millions of Americans. I was disappointed to learn that President Obama’s proposed fiscal year 2013 budget holds NIH funding at its current level, with no increase or adjustment for inflation.
With the threat of future cuts looming, federal investment in biomedical research - and the grants NIH gives to research institutions here in Michigan - are critical, not just to jobs and our state’s economy, but also to my future, and that of my family, and millions of others.
I call on Senators Levin and Stabenow and Representative Dingell to support increased funding to at least $32 billion for the NIH. A sustained investment in research is not simply good policy - it makes sound fiscal sense.
As a resident of Michigan, I want to reduce the federal budget deficit, but not at the cost of future cures and breakthrough discoveries that may save millions of lives and, in the long run, taxpayer dollars.